PMC:7195088 / 21929-22172
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"677","span":{"begin":90,"end":98},"obj":"Species"},{"id":"802","span":{"begin":14,"end":24},"obj":"Chemical"},{"id":"803","span":{"begin":29,"end":47},"obj":"Chemical"},{"id":"804","span":{"begin":52,"end":62},"obj":"Chemical"},{"id":"805","span":{"begin":68,"end":86},"obj":"Chemical"},{"id":"943","span":{"begin":104,"end":112},"obj":"Disease"},{"id":"944","span":{"begin":213,"end":222},"obj":"Disease"}],"attributes":[{"id":"A677","pred":"tao:has_database_id","subj":"677","obj":"Tax:9606"},{"id":"A802","pred":"tao:has_database_id","subj":"802","obj":"MESH:C000606551"},{"id":"A803","pred":"tao:has_database_id","subj":"803","obj":"MESH:D006886"},{"id":"A804","pred":"tao:has_database_id","subj":"804","obj":"MESH:C000606551"},{"id":"A805","pred":"tao:has_database_id","subj":"805","obj":"MESH:D006886"},{"id":"A943","pred":"tao:has_database_id","subj":"943","obj":"MESH:C000657245"},{"id":"A944","pred":"tao:has_database_id","subj":"944","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Comparison of remdesivir vs. hydroxychloroquine vs. remdesivir plus hydroxychloroquine in patients with COVID-19. Open-label adaptive RCT (NCT04321616, not yet recruiting). Primary endpoint: all-cause in-hospital mortality (follow-up 3 weeks)."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T107","span":{"begin":104,"end":112},"obj":"Disease"}],"attributes":[{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Comparison of remdesivir vs. hydroxychloroquine vs. remdesivir plus hydroxychloroquine in patients with COVID-19. Open-label adaptive RCT (NCT04321616, not yet recruiting). Primary endpoint: all-cause in-hospital mortality (follow-up 3 weeks)."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T107","span":{"begin":119,"end":124},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"Comparison of remdesivir vs. hydroxychloroquine vs. remdesivir plus hydroxychloroquine in patients with COVID-19. Open-label adaptive RCT (NCT04321616, not yet recruiting). Primary endpoint: all-cause in-hospital mortality (follow-up 3 weeks)."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T243","span":{"begin":14,"end":24},"obj":"Chemical"},{"id":"T244","span":{"begin":29,"end":47},"obj":"Chemical"},{"id":"T245","span":{"begin":52,"end":62},"obj":"Chemical"},{"id":"T246","span":{"begin":68,"end":86},"obj":"Chemical"},{"id":"T247","span":{"begin":119,"end":124},"obj":"Chemical"}],"attributes":[{"id":"A243","pred":"chebi_id","subj":"T243","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A244","pred":"chebi_id","subj":"T244","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A245","pred":"chebi_id","subj":"T245","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A246","pred":"chebi_id","subj":"T246","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A247","pred":"chebi_id","subj":"T247","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"Comparison of remdesivir vs. hydroxychloroquine vs. remdesivir plus hydroxychloroquine in patients with COVID-19. Open-label adaptive RCT (NCT04321616, not yet recruiting). Primary endpoint: all-cause in-hospital mortality (follow-up 3 weeks)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T161","span":{"begin":114,"end":172},"obj":"Sentence"},{"id":"T162","span":{"begin":173,"end":243},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Comparison of remdesivir vs. hydroxychloroquine vs. remdesivir plus hydroxychloroquine in patients with COVID-19. Open-label adaptive RCT (NCT04321616, not yet recruiting). Primary endpoint: all-cause in-hospital mortality (follow-up 3 weeks)."}